title: GABAA Receptor Binding Assays of Standardized Leonurus cardiaca and Leonurus japonicus Extracts as Well as Their Isolated Constituents.
abstract: A main traditional use of European Leonurus cardiaca and East Asian Leonurus japonicus is in the treatment of neurological disorders such as anxiety, depression, nervousness, and as a sedative for insomnia. However, their mechanism of action is still under discussion. As anxiety and depressive disorders are increasingly being recognized as connected to dysfunctions of the gamma-aminobutyric acid system, the in vitro effects of standardized L. cardiaca and L japonicus extracts as well as five of their isolated constituents, namely, the labdane-type isoleosibirin, the novel iridoid 7R-chloro-6-desoxy-harpagide, the phenylethanoid lavandulifolioside, and the N-containing compounds stachydrine and leonurine, on this type of neuronal receptor were investigated for the first time. Extracts of L. cardiaca and L. japonicus, characterized by reversed-phase high-performance liquid chromatography determination, as well as their above named isolated, possible active constituents of different chemical nature were tested in several receptor binding assays at rat GABAA receptors using [(3)H]-SR95 531 and [(3)H]-Ro-15-1788 (flumazenil)/diazepam control. The L. cardiaca and L. japonicus extracts as well as leonurine inhibited the concentration-dependent binding of [(3)H]-SR95 531 to the gamma-aminobutyric acid site of the gamma-aminobutyric acid type A receptor with a high binding affinity: IC50s 21 µg/ml, 46 µg/ml, and 15 µg/ml, respectively. In contrast, binding to the benzodiazepine site of the rat gamma-aminobutyric acid type A receptor had a 15 to 30 times lower binding affinity than to the gamma-aminobutyric acid site. The presented experiments provide hints that the neurological mechanism of action of L. cardiaca and L. japonicus may essentially be based on their interaction to the gamma-aminobutyric acid site of the gamma-aminobutyric acid type A receptor, while the benzodiazepine site most probably does not contribute to this effect. In the case of L. japonicus, these effects can be at least partially explained by its leonurine constituent, whereas the active principle of L. cardiaca, which does not contain leonurine, is subject to further research as none of the other investigated individual constituents displayed significant activity in the applied test system.
authors.affiliation: Department of Pharmaceutical Biology, Leipzig University, Leipzig, Germany.
authors.forename: Hans Wilhelm
authors.initials: HW
authors.lastname: Rauwald
authors.affiliation: Department of Pharmaceutical Biology, Leipzig University, Leipzig, Germany.
authors.forename: Alex
authors.initials: A
authors.lastname: Savtschenko
authors.affiliation: Department of Pharmaceutical Biology, Leipzig University, Leipzig, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Merten
authors.affiliation: Department of Pharmaceutical Biology, Leipzig University, Leipzig, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Rusch
authors.affiliation: VivaCell Biotechnology, Denzlingen, Germany.
authors.forename: Kurt
authors.initials: K
authors.lastname: Appel
authors.affiliation: National Institute of Health Sciences, Division of Pharmacognosy, Phytochemistry and Narcotics, Setagaya-ku, Tokyo, Japan.
authors.forename: Kenny
authors.initials: K
authors.lastname: Kuchta
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000737:chemistry / Q000378:metabolism*; D005707:Gallic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D006993:Hypnotics and Sedatives; D031332:Leonurus / Q000737:chemistry*; D008297:Male; D015394:Molecular Structure; D010936:Plant Extracts / Q000737:chemistry / Q000378:metabolism*; D011392:Proline / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000378:metabolism*; D012015:Reference Standards; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D014151:Anti-Anxiety Agents; C546281:Gabrg2 protein, rat; D006993:Hypnotics and Sedatives; D010936:Plant Extracts; D011963:Receptors, GABA-A; C013587:leonurine; D005680:gamma-Aminobutyric Acid; D005707:Gallic Acid; D011392:Proline; C003342:stachydrine